Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TCRXTCRX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TSCAN THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 70,514 shares of TCRX (TSCAN THERAPEUTICS INC), worth $69,111 as of 2026-Q2. The position was increased (+89.2% shares).

Current Value

$69,111

Current Shares

70,514

Total Value Change

-$419,335

Total Shares Change

-90,159

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
70,514
+89.2%
$69,1110.0%$0.98
23
2026-Q1
Decreased
37,267
-57.1%
$37,6400.0%$1.03
0
2025-Q4
Decreased
86,903
-33.6%
$86,9030.0%$1.03
0
2025-Q3
Decreased
130,980
-69.5%
$238,3830.0%$1.74
0
2025-Q2
Increased
430,070
+152.5%
$623,6020.0%$1.40
39
2025-Q1
Increased
170,349
+6.0%
$235,0810.0%$1.35
17
2024-Q4
New
160,673
-
$488,4460.0%$3.00
33

Other major holders of TCRX: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Finance, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used